|
US4280918A
(en)
|
1980-03-10 |
1981-07-28 |
International Business Machines Corporation |
Magnetic particle dispersions
|
|
GB9509321D0
(en)
|
1995-05-09 |
1995-06-28 |
Zylepsis Ltd |
Methods of and substances for inhibiting oxidative enzymes
|
|
AU4821697A
(en)
|
1996-10-18 |
1998-05-15 |
Wayne State University |
6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice
|
|
JPH10120597A
(ja)
|
1996-10-22 |
1998-05-12 |
Eiken Chem Co Ltd |
リンパ節高集積性コロイド粒子
|
|
DE69819519T2
(de)
|
1997-08-19 |
2004-09-23 |
Warner-Lambert Co. Llc |
Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
|
|
US7311924B2
(en)
*
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
|
EP1299085B1
(en)
*
|
2000-06-30 |
2005-11-16 |
Inex Pharmaceuticals Corp. |
Improved liposomal camptothecins and uses thereof
|
|
US8178123B2
(en)
|
2001-08-29 |
2012-05-15 |
Femina Pharma Incorporated |
Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
|
|
US20050090732A1
(en)
|
2003-10-28 |
2005-04-28 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles
|
|
CA2547024C
(en)
|
2003-12-22 |
2013-12-17 |
Bracco Research Sa |
Gas-filled microvesicle assembly for contrast imaging
|
|
WO2005086639A2
(en)
|
2004-02-10 |
2005-09-22 |
Barnes-Jewish Hospital |
Improved efficacy and safety of targeted particulate agents with decoy systems
|
|
US20060264804A1
(en)
|
2005-04-07 |
2006-11-23 |
Yoram Karmon |
Device and kit for delivery of encapsulated substances and methods of use thereof
|
|
US20070088414A1
(en)
*
|
2005-05-25 |
2007-04-19 |
Campbell Robert L |
Particulate formulations for intradermal delivery of biologically active agents
|
|
DE102005039579B4
(de)
*
|
2005-08-19 |
2022-06-30 |
Magforce Ag |
Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
|
|
WO2007122956A1
(ja)
*
|
2006-03-24 |
2007-11-01 |
Toto Ltd. |
酸化チタン複合体粒子、その分散液、およびそれらの製造方法
|
|
JP2009536151A
(ja)
|
2006-03-30 |
2009-10-08 |
富士フイルム株式会社 |
ナノ粒子
|
|
EP1852107A1
(en)
|
2006-04-19 |
2007-11-07 |
Nanobiotix |
Magnetic nanoparticles compositions and uses thereof
|
|
JP2009536162A
(ja)
|
2006-05-04 |
2009-10-08 |
ユニバーシティー オブ サウス オーストラリア |
ナノ粒子被覆カプセルからの薬物放出
|
|
CA2697042A1
(en)
|
2007-08-21 |
2009-02-26 |
Alza Corporation |
Liposome compositions for in vivo administration of boronic acid compounds
|
|
FR2922106B1
(fr)
|
2007-10-16 |
2011-07-01 |
Univ Claude Bernard Lyon |
Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants.
|
|
WO2009081287A2
(en)
|
2007-12-21 |
2009-07-02 |
University Of Guelph |
Polysaccharide nanoparticles
|
|
CA2716347C
(en)
|
2008-02-21 |
2017-06-20 |
Sequoia Pharmaceuticals, Inc. |
Amino acid inhibitors of cytochrome p450
|
|
WO2009142754A1
(en)
|
2008-05-22 |
2009-11-26 |
Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dendritic conjugates and methods of use
|
|
EP2130553A1
(en)
*
|
2008-06-05 |
2009-12-09 |
Nanobiotix |
Inorganic nanoparticles of high density to destroy cells in-vivo
|
|
US20130023714A1
(en)
|
2008-10-26 |
2013-01-24 |
Board Of Regents, The University Of Texas Systems |
Medical and Imaging Nanoclusters
|
|
GB0921596D0
(en)
|
2009-12-09 |
2010-01-27 |
Isis Innovation |
Particles for the treatment of cancer in combination with radiotherapy
|
|
US8580312B2
(en)
|
2010-02-17 |
2013-11-12 |
National University Corporation Kobe University |
Radiation therapy agent
|
|
CA3051495A1
(en)
|
2010-03-26 |
2011-09-29 |
Abraxis Bioscience, Llc |
Use of nanoparticles comprising a taxane and albumin in the treatment of hepatocellular carcinoma
|
|
GB201009455D0
(en)
|
2010-06-04 |
2010-07-21 |
King S College London |
Nanoparticles and their uses in molecular imaging
|
|
WO2012051220A1
(en)
|
2010-10-11 |
2012-04-19 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
|
RU2013117288A
(ru)
|
2010-12-17 |
2015-01-27 |
Эрроухэд Рисерч Корпорейшн |
СОДЕРЖАЩАЯ ГАЛАКТОЗНЫЙ КЛАСТЕР НАЦЕЛИВАЮЩАЯ ГРУППА ДЛЯ миРНК, МОДУЛИРУЮЩАЯ ФОРМАКОКИНЕТИЧЕСКИЕ СВОЙСТВА
|
|
CN103429227B
(zh)
|
2011-01-31 |
2017-12-19 |
纳米生物技术公司 |
纳米粒子递送系统、其制备及应用
|
|
EP2670393B8
(en)
*
|
2011-01-31 |
2016-10-05 |
Nanobiotix |
Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
|
|
WO2013059295A2
(en)
|
2011-10-17 |
2013-04-25 |
Trustees Of Boston University |
Polymeric depots for localization of an agent to biological sites
|
|
CN102532154B
(zh)
|
2012-01-11 |
2014-05-14 |
昆明医学院 |
隆萼当归线型呋喃香豆素化合物及其应用
|
|
WO2014039874A2
(en)
|
2012-09-07 |
2014-03-13 |
Carnegie Mellon University |
Methods and materials for reducing reticuloendothelial system clearance of particles from a subject
|
|
ITRM20120480A1
(it)
|
2012-10-09 |
2014-04-10 |
Uni Degli Studi Camerino |
Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione.
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
MA38687A1
(fr)
|
2013-05-30 |
2017-12-29 |
Nanobiotix |
Composition pharmaceutique, préparation et utilisations de celle-ci
|
|
EP2886128A1
(en)
|
2013-12-20 |
2015-06-24 |
Nanobiotix |
Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
|
|
AU2015352685B2
(en)
|
2014-11-25 |
2020-09-17 |
Nanobiotix |
Pharmaceutical composition, preparation and uses thereof
|
|
PL3229843T3
(pl)
|
2014-11-25 |
2020-06-29 |
Curadigm Sas |
Kompozycja farmaceutyczna, wytwarzanie i zastosowanie tej kompozycji
|
|
DK3223796T3
(da)
|
2014-11-25 |
2021-09-27 |
Curadigm Sas |
Farmaceutiske sammensætninger, fremstilling og anvendelser deraf
|
|
WO2016083336A1
(en)
|
2014-11-25 |
2016-06-02 |
Nanobiotix |
Pharmaceutical composition, preparation and uses thereof
|
|
PT3229776T
(pt)
*
|
2014-11-25 |
2023-08-17 |
Curadigm Sas |
Composição farmacêutica combinando pelo menos duas nanopartícuas distintas e um composto farmacêutico, preparaçâo e suas utilizações
|